The compliance beat, finally readable.
The 483 is the daily intelligence brief built for the people who actually do the compliance work — lawyers, scientists, regulatory officers, and the AI/data teams now caught in the same crosshairs.
Skip the $300/year paywalls. Skip the 2,000-word press-release rewrites. Get the stories that move billions, told in the time it takes to finish your coffee.
Built for your team
Scientist and R&D - Clinical-trial integrity, AdComm verdicts, FDA guidance that reshapes your protocols overnight
In-house & outside counsel - SEC enforcement, FCPA, patent wars, quitam, DOJ priorities
Regulatory & QA officers - warning letters, 483 findings, audit patterns
AI safety & data governance leads - how regulators are starting to treat models algorithmic decisions in healthcare and finance
Finance, BD, strategy - deals, disclosure failures, the rules quietly rewriting the playbook
What you get
The Morning Brief — a 90-second daily read-through of what moved overnight. Delivered before market open, 7 AM ET, Mon–Fri.
Six beats, one inbox — FDA, SEC, Deals, Legal, AI, Data Integrity.
Primary sources only — every story traces back to an FDA letter, SEC filing, PACER docket, or 8-K. No press-release rewrites.
AI-screened, human-written — algorithms read hundreds of filings; editors pick the angle, check the math, write the piece.
RSS + archive — pipe into Slack, Notion, or your internal compliance dashboard.
Free. No paywall. No ads. Editorial independence guaranteed.